Authors: Darwin E, Hirt PA, Fertig R, Doliner B, Delcanto G PMID: 29769777 PMCID: PMC5939003 DOI: 10.4103/ijt.ijt_99_17 Abstract Alopecia areata (AA) is a complex autoimmune condition that causes nonscarring hair loss. It typically presents with sharply demarcated round patches of hair loss and may present at any age. In this article, we review the epidemiology, [...]

Authors: Nguyen B, Tosti A PMID: 35224518 PMCID: PMC8860672 DOI: 10.1016/j.jdin.2022.02.006 Abstract Background: COVID-19 is associated with androgenetic alopecia (AGA), telogen effluvium (TE), and alopecia areata (AA). No studies have analyzed the aggregate data to date. Objective: We conducted a systematic review to characterize the types, incidence, timing, and clinical outcomes of COVID-19-associated alopecia. Methods: [...]

Authors: Harvey CJ PMID: 33304703 PMCID: PMC7721078 DOI: 10.7759/cureus.11371 Abstract Alopecia areata (AA) is a common autoimmune condition resulting in spot baldness and, rarely, more extensive hair loss. There is an association between both the incidence and the severity of AA and several micronutrients, including vitamin D and zinc. This case reports an eight-year-old male [...]

Authors: Goren A, Vamo-Galvan S, Wambier CG, McCoy J PMID: 32301221 DOI: 10.1111/jocd.13443 Abstract A preliminary observation of high frequency of male pattern hair loss among admitted COVID-19 patients and suggest that androgen expression might be a clue to COVID-19 severity. Keywords: 5-alpha reductase; ACE2; SARS-CoV-2; TMPRSS2; androgenetic alopecia. Source: https://pubmed.ncbi.nlm.nih.gov/32301221/ Archive: https://archive.ph/BBGXS [...]

Authors: Stoehr JR, Choi JN, Colavincenzo M, Vanderweil S PMID: 30604379 DOI: 10.1007/s40257-018-0409-y Abstract Topical minoxidil is a well-known and often-utilized drug in dermatological practice for the treatment of alopecia. It was approved by the United States Food and Drug Administration for the treatment of androgenetic alopecia in 1988. Since its approval, minoxidil has been [...]

Authors: Nichols AJ, Hughs OB, Canazza A, Zaiac M PMID: 28367262 PMCID: PMC5367873 Abstract Objective: To evaluate the effectiveness of a novel oral supplement, Forti5®, containing green tea extract, omega 3 and 6 fatty acids, cholecalciferol, melatonin, beta-sitosterol, and soy isoflavones, and in the management of subjects with androgenetic alopecia. Design: A prospective case series [...]

Authors: Wikramanayake TC, Villasante AC, Mauro LM, Perez CI, Jimenez JJ PMID: 22042611 PMCID: PMC3273564 DOI: 10.1007/s12192-011-0305-3 Abstract Alopecia areata (AA) is an autoimmune non-scarring hair loss disorder. AA can be acute, recurrent, or chronic. Current therapeutic options for AA are limited, and there is no effective prevention for recurrent AA. We have previously shown [...]